Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Database
Language
Publication year range
1.
J Neurochem ; 78(3): 515-23, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11483654

ABSTRACT

It has recently been shown that transition metal cations Zn2+ and Cu2+ bind to histidine residues of nerve growth factor (NGF) and other neurotrophins (a family of proteins important for neuronal survival) leading to their inactivation. Experimental data and theoretical considerations indicate that transition metal cations may destabilize the ionic form of histidine residues within proteins, thereby decreasing their pK(a) values. Because the release of transition metal cations and acidification of the local environment represent important events associated with brain injury, the ability of Zn2+ and Cu2+ to bind to neurotrophins in acidic conditions may alter neuronal death following stroke or as a result of traumatic injury. To test the hypothesis that metal ion binding to neurotrophins is influenced by pH, the effects of Zn2+ and Cu2+ on NGF conformation, receptor binding and NGF tyrosine kinase (trkA) receptor signal transduction were examined under conditions mimicking cerebral acidosis (pH range 5.5-7.4). The inhibitory effect of Zn2+ on biological activities of NGF is lost under acidic conditions. Conversely, the binding of Cu2+ to NGF is relatively independent of pH changes within the studied range. These data demonstrate that Cu2+ has greater binding affinity to NGF than Zn2+ at reduced pH, consistent with the higher affinity of Cu2+ for histidine residues. These findings suggest that cerebral acidosis associated with stroke or traumatic brain injury could neutralize the Zn2+-mediated inactivation of NGF, whereas corresponding pH changes would have little or no influence on the inhibitory effects of Cu2+. The importance of His84 of NGF for transition metal cation binding is demonstrated, confirming the involvement of this residue in metal ion coordination.


Subject(s)
Copper/metabolism , Nerve Growth Factor/metabolism , Zinc/metabolism , Acidosis/metabolism , Animals , Autoradiography , Brain Diseases/metabolism , Humans , Hydrogen-Ion Concentration , Immunoblotting , Iodine Radioisotopes/metabolism , Kinetics , Mice , Nerve Growth Factor/genetics , PC12 Cells , Phosphorylation , Protein Binding , Protein Conformation , Rats , Receptor, Nerve Growth Factor/chemistry , Receptor, Nerve Growth Factor/isolation & purification , Receptor, Nerve Growth Factor/metabolism , Receptor, trkA/chemistry , Receptor, trkA/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Signal Transduction , Surface Plasmon Resonance
2.
Cell Death Differ ; 8(5): 451-6, 2001 May.
Article in English | MEDLINE | ID: mdl-11423905

ABSTRACT

It has previously been documented that Zn2+ inhibits TrkA-mediated effects of NGF. To evaluate the ability of Zn2+ to attenuate the biological activities of NGF mediated by p75NTR, we characterized the effects of this transition metal cation on both binding and the pro-apoptotic properties of the NGF-p75NTR interaction. Binding of NGF to p75NTR displayed higher affinity in embryonic chick retinal cells than in PC12 cells. NGF induced apoptosis in dissociated cultures of chick neural retina. The addition of 100 microM Zn2+ inhibited binding and chemical cross-linking of 125I-NGF to p75NTR, and also attenuated apoptosis mediated by this ligand-receptor interaction. These studies lead to the conclusion that Zn2+ antagonizes NGF/p75NTR-mediated signaling, suggesting that the effect of this transition metal cation can be either pro- or anti-apoptotic depending on the cellular context.


Subject(s)
Apoptosis/drug effects , Receptors, Nerve Growth Factor/antagonists & inhibitors , Receptors, Nerve Growth Factor/metabolism , Retina/drug effects , Zinc/pharmacology , Animals , Cations, Divalent/pharmacology , Chick Embryo , Nerve Growth Factor/antagonists & inhibitors , Nerve Growth Factor/metabolism , Nerve Growth Factor/pharmacology , PC12 Cells , Protein Binding/drug effects , Quinazolines/pharmacology , Rats , Receptor, Nerve Growth Factor , Retina/cytology , Substrate Specificity
3.
Protein Sci ; 8(11): 2223-33, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10595525

ABSTRACT

Neurotrophins are a family of proteins with pleiotropic effects mediated by two distinct receptor types, namely the Trk family, and the common neurotrophin receptor p75NTR. Binding of four mammalian neurotrophins, nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4/5 (NT-4/5), to p75NTR is studied by molecular modeling based on X-ray structures of the neurotrophins and the extracellular domain of p55TNFR, a homologue of p75NTR. The model of neurotrophin/receptor interactions suggests that the receptor binding domains of neurotrophins (loops I and IV) are geometrically and electrostatically complementary to a putative binding site of p75NTR, formed by the second and part of the third cysteine-rich domains. Geometric match of neurotrophin/receptor binding domains in the complexes, as characterized by shape complementarity statistic Sc, is comparable to known protein/protein complexes. All charged residues within the loops I and IV of the neurotrophins, previously determined as being critical for p75NTR binding, directly participate in receptor binding in the framework of the model. Principal residues of the binding site of p75NTR include Asp47, Lys56, Asp75, Asp76, Asp88, and Glu89. The additional involvement of Arg80 and Glu53 is specific for NGF and BDNF, respectively, and Glu73 participates in binding with NT-3 and NT-4/5. Neurotrophins are likely to induce similar, but not identical, conformational changes within the p75NTR binding site.


Subject(s)
Nerve Growth Factors/chemistry , Nerve Growth Factors/metabolism , Receptors, Nerve Growth Factor/chemistry , Receptors, Nerve Growth Factor/metabolism , Amino Acid Sequence , Animals , Binding Sites , Brain-Derived Neurotrophic Factor/chemistry , Brain-Derived Neurotrophic Factor/metabolism , Mammals , Models, Molecular , Molecular Sequence Data , Neuroprotective Agents/chemistry , Neuroprotective Agents/metabolism , Neurotrophin 3/chemistry , Neurotrophin 3/metabolism , Protein Conformation , Protein Structure, Secondary
4.
Eur J Neurosci ; 10(3): 890-8, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9753156

ABSTRACT

Equilibrium binding of 125I-nerve growth factor (125I-NGF) to cells coexpressing the tyrosine kinase receptor A (TrkA) and common neurotrophin receptor (p75NTR), cells coexpressing both receptors where p75NTR is occupied, and cells expressing only p75NTR, revealed reciprocal modulation of receptor affinity states. Analysis of receptor affinity states in PC12 cells, PC12 cells in the presence of brain-derived neurotrophic factor (BDNF), and PC12nnr5 cells suggested that liganded and unliganded p75NTR induce a higher affinity state within TrkA, while TrkA induces a lower affinity state within p75NTR. These data are consistent with receptor allosterism, and prompted a search for TrkA/p75NTR complexes in the absence of NGF. Chemical crosslinking studies revealed high molecular weight receptor complexes that specifically bound 125I-NGF, and were immunoprecipitated by antibodies to both receptors. The heteroreceptor complex of TrkA and p75NTR alters conformation and/or dissociates in the presence of NGF, as indicated by the ability of low concentrations of NGF to prevent heteroreceptor crosslinking. These data suggest a new model of receptor interaction, whereby structural changes within a heteroreceptor complex are induced by ligand binding.


Subject(s)
Proto-Oncogene Proteins/metabolism , Receptor Protein-Tyrosine Kinases/metabolism , Receptors, Nerve Growth Factor/metabolism , Animals , Brain-Derived Neurotrophic Factor/metabolism , Cross-Linking Reagents , Ligands , Models, Neurological , Molecular Weight , Nerve Growth Factors/metabolism , PC12 Cells , Phosphorylation , Precipitin Tests , Proto-Oncogene Proteins/chemistry , Rats , Receptor Protein-Tyrosine Kinases/chemistry , Receptor, Nerve Growth Factor , Receptor, trkA , Receptors, Nerve Growth Factor/chemistry , Signal Transduction/physiology
5.
Nat Med ; 3(8): 872-8, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9256278

ABSTRACT

A role for Zn2+ in a variety of neurological conditions such as stroke, epilepsy and Alzheimer's disease has been postulated. In many instances, susceptible neurons are located in regions rich in Zn2+ where nerve growth factor (NGF) levels rise as a result of insult. Although the interaction of Zn2+ with this neurotrophin has previously been suggested, the direct actions of the ion on NGF function have not been explored. Molecular modeling studies predict that Zn2+ binding to NGF will induce structural changes within domains of this neurotrophin that participate in the recognition of TrkA and p75NTR. We demonstrate here that Zn2+ alters the conformation of NGF, rendering it unable to bind to p75NTR or TrkA receptors or to activate signal transduction pathways and biological outcomes normally induced by this protein. Similar actions of Zn2+ are also observed with other members of the NGF family, suggesting a modulatory role for this metal ion in neurotrophin function.


Subject(s)
Nerve Growth Factors/physiology , Zinc/physiology , Animals , Chickens , Mice , Nerve Growth Factors/chemistry , Nerve Growth Factors/metabolism , Neurites , PC12 Cells , Protein Binding , Protein Conformation , Rats , Receptor, Nerve Growth Factor , Receptor, trkA/metabolism , Receptors, Nerve Growth Factor/metabolism
6.
Mol Pharmacol ; 47(3): 624-9, 1995 Mar.
Article in English | MEDLINE | ID: mdl-7700259

ABSTRACT

The equilibrium structures of 20 intercalated physical complexes of "bay-region" triol carbocations of polycyclic aromatic hydrocarbons (PAHs) with B-DNA are obtained by AMBER molecular modeling. The complexes with highly potent carcinogens are found (i) to undergo only minor conformational changes upon complexation, (ii) to be stabilized by hydrogen bonds between two hydroxyl groups of the triol carbocations and N3 atoms of the adjacent guanine residues, and (iii) to be "preorganized" for covalent bonding. A new explanation for the absolute stereochemical and shape dependence of carcinogenesis by PAHs is presented. The biologically active conformers of both carcinogenic stereoisomers (anti and syn) of triol carbocations are characterized by a quasi-diaxial orientation of the neighboring hydroxyl groups and fulfill the spatial requirements for hydrogen bonding to the adjacent guanine residues of B-DNA. The striking dependence of potency on the shape of the PAHs is largely caused by repulsion from the C2'-methylene groups of the deoxyribose residues of DNA. This interaction may shift the intercalated triol carbocation, thereby enhancing or reducing the preorganization for covalent bonding. The molecular modeling study is augmented by benchmark ab initio calculations on the bay-region triol carbocation of phenanthrene.


Subject(s)
Carcinogens/chemistry , Carcinogens/metabolism , DNA/chemistry , DNA/metabolism , Polycyclic Compounds/chemistry , Polycyclic Compounds/metabolism , Carcinogens/toxicity , DNA/drug effects , Models, Molecular , Molecular Conformation , Nucleic Acid Conformation , Oligodeoxyribonucleotides/chemistry , Polycyclic Compounds/toxicity , Stereoisomerism , Thermodynamics
7.
J Steroid Biochem ; 32(6): 857-63, 1989 Jun.
Article in English | MEDLINE | ID: mdl-2547115

ABSTRACT

Twenty-two Steroid molecules have been tested for the inhibition Na,K-dependent ATPase at 10(-7)-10(-4) M concentrations. At the 10(-5) M concentration of the investigated molecules, inhibition ranged from 8 to 36%. To explain the structure-inhibition % relationship, we determined the value of heteropolarity or biphilicity moment of these molecules. This value would appear to be dependent on the space location and hydrophilicity of the molecule elementary fragments, and to the degree of their water accessibility; however, it is independent of the hydrophilicity of the molecules as a whole. On the basis of the obtained data, details of Na,K-ATPase digitalis-receptor structure and the mechanism of the glycoside-receptor interaction are discussed.


Subject(s)
Receptors, Drug/analysis , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors , Steroids/pharmacology , Binding Sites , Cardenolides/pharmacology , Digitalis Glycosides/analysis , Models, Theoretical , Molecular Structure , Receptors, Drug/drug effects , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL